APA (7th ed.) Citation

Halton, J., & Brückmann, M. (2017). Pharmacokinetics, pharmacodynamics, safety and tolerability of dabigatran etexilate oral liquid formulation in infants with venous thromboembolism. Thrombosis and haemostasis, 117(11), . https://doi.org/10.1160/TH17-06-0429

Chicago Style (17th ed.) Citation

Halton, Jacqueline, and Martina Brückmann. "Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate Oral Liquid Formulation in Infants with Venous Thromboembolism." Thrombosis and Haemostasis 117, no. 11 (2017). https://doi.org/10.1160/TH17-06-0429.

MLA (9th ed.) Citation

Halton, Jacqueline, and Martina Brückmann. "Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate Oral Liquid Formulation in Infants with Venous Thromboembolism." Thrombosis and Haemostasis, vol. 117, no. 11, 2017, https://doi.org/10.1160/TH17-06-0429.